Moreira, D M
de O Freitas, D M
Nickel, J C
Andriole, G L
Castro-Santamaria, R
Freedland, S J
Article History
Received: 24 February 2017
Revised: 6 April 2017
Accepted: 17 April 2017
First Online: 6 June 2017
Competing interests
: I certify that all conflicts of interest, including specific financial interests and relationships and affiliations relevant to the subject matter or materials discussed in the manuscript (eg, employment/ affiliation, grants or funding, consultancies, honoraria, stock ownership or options, expert testimony, royalties, or patents filed, received or pending) are the following: DdOF, JCN and DMM have no disclosures; GLA Jr: consulting and advisory board (GlaxoSmithKline, PLC), speaker fees (GlaxoSmithKline, PLC), research support (GlaxoSmithKline, PLC); RC-S: employee (GlaxoSmithKline, PLC); SF: research support (GlaxoSmithKline, PLC).